Zinc in early life: A key element in the fetus and preterm neonate by Terrin, Gianluca et al.
Review
Zinc in Early Life: A Key Element in the Fetus and
Preterm Neonate
Gianluca Terrin 1,*, Roberto Berni Canani 2, Maria Di Chiara 1, Andrea Pietravalle 1,
Vincenzo Aleandri 1,3, Francesca Conte 4 and Mario De Curtis 4
Received: 8 August 2015; Accepted: 26 November 2015; Published: 11 December 2015
1 Department of Gynecology-Obstetrics, University of Rome La Sapienza, Rome 00186, Italy;
mariadc91@hotmail.it (M.D.C.); apietravalle@gmail.com (A.P.); vincenzo.aleandri@uniroma1.it (V.A.)
2 Department of Translational Medicine, University of Naples Federico II, Napoli 80138, Italy;
berni@unina.it
3 Research Center on Evaluation of Quality in Medicine—CEQUAM, University of Rome La Sapienza,
Rome 00186, Italy
4 Department of Pediatrics, University of Rome La Sapienza, Rome 00186, Italy; frconte2000@yahoo.it (F.C.);
mario.decurtis@uniroma1.it (M.D.C.)
* Correspondence: gianluca.terrin@uniroma1.it; Tel.: +0039-064-997-2536
Abstract: Zinc is a key element for growth and development. In this narrative review, we focus
on the role of dietary zinc in early life (including embryo, fetus and preterm neonate), analyzing
consequences of zinc deficiency and adequacy of current recommendations on dietary zinc. We
performed a systematic search of articles on the role of zinc in early life. We selected and analyzed
81 studies. Results of this analysis showed that preservation of zinc balance is of critical importance
for the avoidance of possible consequences of low zinc levels on pre- and post-natal life. Insufficient
quantities of zinc during embryogenesis may influence the final phenotype of all organs. Maternal
zinc restriction during pregnancy influences fetal growth, while adequate zinc supplementation
during pregnancy may result in a reduction of the risk of preterm birth. Preterm neonates are
at particular risk to develop zinc deficiency due to a combination of different factors: (i) low
body stores due to reduced time for placental transfer of zinc; (ii) increased endogenous losses;
and (iii) marginal intake. Early diagnosis of zinc deficiency, through the measurement of serum
zinc concentrations, may be essential to avoid severe prenatal and postnatal consequences in these
patients. Typical clinical manifestations of zinc deficiency are growth impairment and dermatitis.
Increasing data suggest that moderate zinc deficiency may have significant subclinical effects,
increasing the risk of several complications typical of preterm neonates (i.e., necrotizing enterocolitis,
chronic lung disease, and retinopathy), and that current recommended intakes should be revised to
meet zinc requirements of extremely preterm neonates. Future studies evaluating the adequacy of
current recommendations are advocated.
Keywords: micronutrients; neonate; newborn; fetus; low birth weight; growth; dermatitis;
Necrotizing enterocolitis
1. Introduction
Zinc is one of the most abundant trace elements in humans [1]. Zinc is functional for the
activity of a number of proteins (i.e., enzymes, membrane proteins, gene-regulatory proteins, and
hormonal receptors) involved in most major metabolic pathways [2]. Zinc interacts with proteins
in different ways: (i) by promoting enzymatic processes; (ii) by maintaining quaternary structure
stability (Figure 1) [2]; or (iii) by favoring interactions with other molecules (i.e., proteins, nucleic
acids) [3]. The six enzyme classes established by the International Union of Biochemistry Enzymes,
Nutrients 2015, 7, 10427–10446; doi:10.3390/nu7125542 www.mdpi.com/journal/nutrients
Nutrients 2015, 7, 10427–10446
i.e., oxidoreductases, transferases, hydrolases, lysases, isomerases and ligases, all require zinc [1].
During the enzymatic processes, zinc may have (1) a catalytic role (it has roles directly in catalytic
processes), (2) a coactive role (by enhancing or diminishing catalytic functions) and a structural role
(it is required for quaternary structure stability of enzymes) [4]. Metallothioneins (MTs) are the most
abundant cysteine-rich proteins containing zinc [5]. These proteins have an important antioxidant
activity and stabilize cell membranes only in the presence of zinc [6]. Zinc is also required for the DNA
binding proteins involved in the regulation of gene expression [7–9]. The glucocorticoid and estrogen
receptors are examples of zinc hormonal receptor proteins. They are members of a multigene family
that includes receptors for thyroid hormone, retinoic acid, and vitamin D [10]. The DNA binding
domain of these proteins contains zinc. Removal of this element yields hormonal receptors that do
not bind DNA when activated by glucocorticoids or estrogens.
Figure 1. Zinc role in stabilizing protein quaternary structure [2].
The characteristic of the zinc is, certainly, its even distribution throughout the body. Functionally,
zinc participates in cell division and growth, intestinal electrolyte absorption, neurotransmission,
immune response, thymus activity, and vision (Figure 2) [11–17]. Consequently, numerous functions
in humans are affected by zinc deficiency, particularly during periods of increased metabolism.
However, clinical manifestations become evident only with severe deficiency; dermatitis, diarrhea,
neurological disorders, growth failure, infections and delayed tissue healing following injuries are
the most frequent clinical consequences of zinc deficiency. In early life, zinc deficiency may affect
embryogenesis and may influence duration of pregnancy. After birth, a major factor associated with
the development of zinc deficiency is its inadequate intake. Additional exacerbating factors include
high physiological requirements, excessive losses by pathological conditions, intestinal failure and
treatment with some drugs [18]. With some degree of variability, as with many other nutrients, human
do not have functional reserves or body stores of available zinc, except neonates born at term, who
may be able to draw on the hepatic zinc accumulated during the entire gestational period [19]. These
aspects are of particular importance for preterm neonates. In this population, high requirements
for growth and environmental injuries, physiological intestinal insufficiency and frequent use of
antibiotics, significantly increase the risk of zinc deficiency. In addition, preterm birth reduces the
duration of pregnancy and thus the amount of hepatic stores available during periods of reduced
zinc intake.
Consequently, preservation of a positive zinc balance in the mother during pregnancy and
lactation, and in neonates, is of critical importance in early life for the possible consequences on
health, growth and development.
Starting from these considerations, we carried out a narrative review, analyzing current
literature, with the subsequent aims to:
1. Explore the role of zinc in early life including embryogenesis, fetal and neonatal life.
2. Analyze the criteria used for the diagnosis of zinc deficiency in preterm neonates.
3. Investigate the consequences of zinc deficiency in preterm neonates.
4. Evaluate the adequacy of current recommendations on zinc for preterm neonates.
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5. Suggest new possible research perspectives on the use of zinc in early life.
Figure 2. Zinc functions in early life [11–17].
2. Evidence Selection Method
We performed a systematic search of articles on the role of zinc in embryogenesis, during fetal
life and in babies born prematurely. We conducted an electronic search in MEDLINE using the
following medical subject headings and terms: “zinc” associated with “embryogenesis”, “fetus”,
“preterm neonate” or “preterm newborn”. In addition, we made a manual search of the reference
lists of all eligible articles. We limited the search to clinical trials, case reports and reviews in human
and animal model, in English language. We selected and analyzed 81 studies (Table 1) and report the
results here in a narrative review.
Table 1. Evidence selection.
Medical Subject
Headings and Terms
Zinc AND
Embryogenesis Zinc AND Fetus
Zinc AND Preterm Neonate or
Zinc AND Preterm Newborn
Eligible articles 196 100 155
Excluded articles (reasons) 188 (unrelated articles) 86 (unrelated articles) 96 (unrelated articles)
Selected articles, n 8 14 59
-Human 4 11 55
-Animal 4 3 4
3. Function of Zinc during Fetal and Neonatal Life
3.1. The Role of Zinc in Embryogenesis
An adequate supply of maternal zinc is essential for embryogenesis. A major role of zinc
is the regulation of chromatin structure and function and, thus, the expression of genes essential
for embryogenesis [20]. Consequently, insufficient quantities of zinc during embryogenesis may
influence the final phenotype of all organs [21]. Maternal zinc deprivation increases the risk of fetal
mortality, growth retardation and malformations, including neural tube defects as demonstrated in
clinical trials [22–24]. The vast majority of the evidence on the role of zinc in embryogenesis derives
from the observation of the phenomenological effects of its deficiency in animal models rather than
in human pregnancies (Table 2) [25–32]. Particular attention should be given to alcohol intake during
pregnancy. Alcohol alters zinc metabolism and induces severe consequences on the fetus [33–39]
Many of the clinical manifestation typical of the alcoholic fetal syndrome may be specifically related
to zinc deficiency [33–39].
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Table 2. The role of zinc in embryogenesis. Evidence from animal and human studies.
A. Evidence from Experimental Animal Model.
Study Model Study Design Main Results
Hurley et al.,
1969 [25] Pregnant rats
Severe zinc deficiency induced by the use of a diet
containing isolated soybean protein (treated with a
chelating agent). Controls fed with
zinc-supplemented diet
98% of full-term fetuses with congenital
malformations of the tail (72%), finger (64%),
lungs (54%), palate (42%), brain (47%), eye
(42%), feet (38%), urogenital tract (21%)
Hicory et al.,
1979 [26] Pregnant rats
Eighteen rats fed with zinc deficient diet and 18 fed
with zinc supplemented diet during pregnancy
Malformations of the trunk and limbs in fetuses
of zinc deficient mothers
Rogers et al.,
1985 [27]
Long-Evans hooded pregnant
rats and fetuses
Determination of teratogenicity of maternal Zn
deficiency in the Long-Evans hooded rat,
examining the effects of Zn deficiency on Zn, Fe,
and Cu concentrations in maternal and fetal
tissues. Evaluation of the effects of Zn deficiency
on the risk of abdominal and skeletal
malformations
All fetuses presented malformations when zinc
was supplemented at low doses
Falchuk et al.,
2001 [28] Frog embryos
Deprivation of zinc in embryos to evaluate the
effects on metallo-proteins activity and on organ
formation and development
Agenesis of dorsal organs (including brain,
eyes and spinal cord) in embryos developed in
the absence of zinc.
B. Evidence from Clinical Studies in Human.
Study Population Study Design Results
Velie et al.,
1999 [29]
Mothers of infants with neural tube
defect (NTD) compared with mothers of
healthy neonates (controls)
Retrospective study on pre-conceptional use of
vitamin, mineral, and food supplements, by filling
a specific questionnaire
Risk of NTDs decreased with the increase in
maternal pre-conceptional zinc intake
Cengiz et al.,
2004 [30]
Mothers of infants with neural tube
defect diagnosed in the second trimester
of gestation compared with mothers of
healthy neonates (controls)
Case-control study to investigate the relationship
between maternal micronutrient serum level
(including zinc) and NTD occurrence in neonates
No strict correlation between zinc
concentrations and NTD
Zeyreks et al.,
2009 [31]
Mothers of infants with neural tube
defect (NTD) compared with mothers of
healthy neonates (controls)
Case-control study to investigate the relation
between cord blood and maternal micronutrient
serum levels of (including zinc) and NTD
occurrence in neonates
The mean maternal serum zinc level in mothers
of neonates with NTD was significantly lower
than those of controls
Dey et al.,
2010 [32]
Mothers of infants with neural tube
defects (NTD) compared with mothers
of healthy neonates (controls).
Hospital-based case-control study conducted with
the objective of finding the relationship between
serum zinc levels in newborns and their mothers
and NTDs in a Bangladeshi population
NTD were more likely in subjects born from
mothers with lower serum zinc level
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3.2. Metabolism of Zinc in Fetal Life
Most fetal zinc accretion occurs after the 24th week of gestation [40]. As gestation progresses,
fetal zinc concentrations constantly increase [3]. Zinc is stored in the fetal liver, [3] and transport and
accumulation of zinc in the liver is mediated by MTs. Induction of hepatic MTs activities results in
hepatic zinc accumulation.
In the last trimester, the mother transfers to the fetus up to 1.5 mg/Kg of zinc every day [41].
Placental transfer of zinc to the fetus is mediated mainly by an endocytic mechanism [42].
Affinity for zinc by the placenta does not vary with gestational age or with low maternal plasma zinc
concentrations. Zinc deficiency in the fetus is observed only in the presence of severe maternal zinc
deficiency, because placental transfer of this element is an active process and fetal zinc concentrations
are maintained constantly higher than maternal levels [41]. On the other hand, the absence of a
ready mechanism for adjusting possible fetal zinc deprivation reduces the effects of maternal zinc
supplementation during pregnancy.
Evidence from rodent models and humans suggests that maternal zinc restriction during
pregnancy influences fetal growth and health [25]. In humans, conflicting results have been obtained
when this relation has been explored. A recent Cochrane meta-analysis, including 21 randomized
controlled trials involving over 17,000 women, demonstrated that maternal zinc supplementation
during pregnancy resulted in a reduction in preterm birth (risk ratio 0.86, 95% confidence interval
0.76–0.97) [43]. No clear benefit of zinc supplementation was demonstrated on many other maternal
and neonatal outcomes, except for induction of labor in a single trial. On basis of their results, the
authors suggest that since the preterm association could well reflect poor nutrition, studies to address
ways of improving the overall nutritional status of populations in impoverished areas, rather than
focusing on micronutrient and or zinc supplementation in isolation, should be considered as priority.
However, many important aspects should be considered during the interpretation of the results of
meta-analyses. The evidence for reduction in preterm birth was primarily demonstrated in trials
involving low-income women. In some of these trials, women were also given other micronutrients
(i.e., iron, folate, vitamins or a combination of these). Risk of bias was high or unclear for many
studies included in the analysis. Finally, the effects of maternal zinc supplementation on neonatal
morbidities and long-term growth and neurodevelopment were investigated only in a small number
of trials, reporting conflicting results [43]. However, consistent evidence has shown that maternal
zinc supplementation starting in the second trimester and discontinued at delivery is associated with
decreased infectious diseases during the first six months of infancy, presumably as a consequence of
a positive effect of zinc on the immune response in early life [44].
Further studies may be useful to establish whether isolated zinc deficit may have consequences
on otherwise well-nourished women and whether specific supplementation, in these cases, could
improve fetal and neonatal short and long-term outcomes.
Specific diet regimens may increase the risk of zinc deficiency in women [45–47]. Table 3 reports
different risks deriving from low zinc intake in women, according to diet regimen [45–47]. The current
understanding of zinc homeostasis indicates that the primary determinants of zinc absorption are
the amounts of ingested phytate, other than zinc [45–47]. High consumption of phytate reduces
zinc absorption. The diet regimen should be monitored in pregnant women, to reduce the risk of
zinc deficiency.
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Table 3. Risk magnitude of zinc deficiency during pregnancy according to maternal diet [45–47].
Risk of Zinc Deficiency Diet Characteristics
Low Adequate protein content mainly from non-vegetable sources (i.e., meat orfish), low cereals intake (phytate intake <500 mg/day)
Moderate Mixed diet containing animal or fish protein, vegetarian or vegan diet notbased on cereal or flours (phytate intake of 500–1500 mg/day)
High Low animal protein intake, high unrefined, unfermented andungerminated * cereals intake (phytate intake >1500 mg/day)
Note: * Germination of cereal grains or fermentation (e.g., leavening) of many flours can reduce antagonistic
potency of phytates on zinc absorption.
4. Neonatal Zinc Metabolism
Zinc deficiency has been well documented in hospitalized premature neonates [48]. The risk
of zinc deficiency increases in preterm and small for gestational age (SGA) neonates or in case of
intestinal failure [49]. The high risk of deficiency derives from a combination of three main factors:
(i) low body stores due to reduced time for placental transfer of zinc; (ii) potentially marginal
intake, and (iii) increased endogenous losses. Intestinal zinc absorption is not regulated by zinc
status, rather, it is absorbed as a percentage of intake. However, in term babies, zinc absorption
improves with decreasing serum zinc concentration and zinc stores are mobilized, enabling infants
to avoid clinical deficiency. Zinc content in human milk varies considerably (0.7 to 1.6 mg/L)
and declines with time [50–54]; while colostrum contains 8–12 mg/L, human milk at seven days
of neonatal life contains 3–6 mg/L of zinc [50–54]. These values rapidly decrease at 1–3 mg/L at
1 month of life [50–54]. No clear differences in the zinc content of human milk were seen in women
taking mineral supplements [50–54]. Preterm infant consuming 180 mL/kg per day of supplemented
human milk would receive only 0.5–1 mg/kg per day of zinc [50–54]. Formula milk concentration
of zinc is 1.5–6 mg/L [50–54]. Despite the greater concentration of zinc in formulas, net absorption
was significantly improved with human milk as compared with formulas (60% vs. 20%) [50–54].
Absorption is slightly decreased in fortified preterm human milk as a percentage, although net
absorption increases [50–54]. Endogenous fecal zinc losses are estimated to range between 50 and
150 mcg/kg per day [55,56]. The gastrointestinal tract is the major site of zinc losses, resulting from
the secretion of endogenous zinc into the lumen and subsequent excretion in the feces. The amount of
zinc excreted in the feces could be considered as a pool of rescue that could be reabsorbed and used
according to host zinc status. However, the amount of zinc reabsorbed may also be influenced by
the occurrence of pathological condition such as diarrhea and steatorrhea [55,56]. Urinary excretion
of zinc is high in extremely preterm neonates (35 mcg/kg per day) in comparison with at term
babies [55,57]. In the absence of adequate supplementation, serum zinc concentrations decline rapidly
during the first months of life (Figure 3) [58–61].
Figure 3. Serum zinc concentrations in preterm neonates by days of life [58–61].
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A series of zinc transporter proteins (ZnT-1, ZnT-2, and ZnT-4) have been identified in the
mammary gland [62]. In rare cases, the mammary gland may have a defect in the ZnT-4 gene,
resulting in impaired secretion of zinc in breast milk. Breast milk zinc concentrations are below
the normal range at all stages of lactation in these women [63]. Infants breast-fed by these mothers
typically display the classic phenotype of acrodermatitis enteropathica already at approximately two
months of postnatal age [63]. This syndrome has been described in term infants but is more likely to
affect infants born preterm, suggesting an increased vulnerability of the preterm infant to clinically
significant zinc deficiency syndromes [49]. Zinc concentrations in human milk may be influenced
by vitamin A status, which regulates zinc transporters in the mammary gland (Table 4) [64–74]. In
addition, the metabolism of zinc and vitamin A seems to be interrelated [72,74,75]. Severe vitamin
A deficiency may reduce the absorption and lymphatic transport of zinc by altering synthesis of a
zinc-dependent binding protein [75]. This aspect should be considered when zinc is supplemented
in neonates receiving fortified human milk and multivitamin products containing vitamin A. These
considerations suggest evaluating vitamin A supplementation, in addition to zinc supplementation,
in neonates with evidence of zinc deficiency and in their mothers. However, the evidence of a strict
zinc-vitamin A interaction in preterm neonates is still lacking.
Table 4. Mechanisms of the influence of other nutrients on zinc metabolism.
Nutrient Mechanism
Proteins [64–68]
Protein is a major source of zinc, thus increased protein intake results in
increased zinc intake
High amounts of protein in enteral nutrition improve zinc absorption
Casein in cow milk reduces zinc absorption
Lipids [69] Fecal zinc increases in subjects with steatorrheaMedium-chain triglycerides improve zinc absorption
Copper [70]
Slight increase in copper intake does not interfere with zinc absorption if
zinc intake is satisfactory. The effects of increased copper intake in
subjects with low intake of zinc still remain to be defined.
Iron [71]
Iron administered at high doses (i.e., iron-zinc ratio of 25:1 molar) reduce
zinc absorption.
Duration of iron supplementation does not affect zinc status
Vitamin A [72] Severe vitamin A deficiency may reduce absorption and lymphatictransport of zinc by altering synthesis of zinc-dependent protein
Folic acid [73] Supplementation with folate may impair zinc absorption by insolublechelate formation
5. Diagnosis of Zinc Deficiency in Preterm Neonate
Accurate biomarkers of zinc status are still lacking. Measurement of serum zinc concentrations
remains the best—albeit imperfect—marker to identify zinc deficiency (Table 5) [76–79]. Based on the
data obtained from cord blood at birth, it is reasonable to identify a condition of zinc deficiency with
serum concentrations at birth below 55 mcg/dL (8.4 mcmol/L) [80]. Serum zinc levels measured in
cord blood at birth are higher in preterm compared with at term neonates (Table 6) [81–86]. Figure 3
depicts serum levels of zinc in preterm neonates in the first 28 days of life [58–61]. In preterm
neonates, serum zinc levels rapidly decline during the first month of life, so that, at post-conceptional
age of 40 weeks, serum zinc concentrations may be lower in preterm neonates compared with term
neonates [58–61].
Typical clinical manifestations are commonly observed only for conditions of severe zinc
deficiency. Increasing data suggest significant subclinical effects of a moderate zinc deficiency in
preterm neonate [87]. Thus, an increase in zinc supplementation should be considered in all neonates
with reduced serum zinc concentrations.
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Table 5. Diagnostic tools for the diagnosis of zinc deficiency.
Biologic Samples Used for Zinc
Concentrations Measurement Characteristics Limitations on the Use in Preterm Neonate
Serum or plasma [76]
It is the only biochemical indicator recommended by WHO to
assess zinc status.
Levels vary according to zinc intakes
It may be used to predict response to zinc supplementation
It is readily available as an early marker of severe deficit
Adventitious zinc can easily be added to samples by environmental
exposure and inappropriate sample handling
Zinc is released from hemolysed red blood cells into the serum.
Low specificity (serum zinc concentrations decrease with a number
of conditions such as infection, trauma, stress, steroid use,
metabolic redistribution of zinc from the plasma to the tissues,
concurrent nutrient deficiency).
Starvation can induce the release of zinc in the circulation.
The time of the day when blood samples are drawn has a
significant effect on serum zinc concentrations (serum zinc is higher
in morning samples than in afternoon or evening samples)
Intracellular concentrations
(erythrocytes, platelets,
leucocytes) [76,77]
Provides information on zinc status over a longer time period
(independent of serum turn-over).
Absence of standardization and reference values in neonates
Large volumes of blood required for the assay
Sophisticated technology useful to isolate cells
Metalloenzymes [78] Rapid response to zinc supplementation No data on diagnostic accuracy in preterm neonates.
Hair [79]
Provides information on zinc status over a longer time period
Easy to collect
Variability with age, sex, season, hair growth rate, and hair color
No standardized methods for collection, washing, and analysis of
hair samples in neonates
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Table 6. Zinc levels in neonatal cord blood at birth by gestational age and birth weight.
Reference Number ofNeonates
Gestational Age
at Birth, Weeks Birth Weight, g
Mean Values ˘ Standard
Deviation (µg/dL)
Jeswani et al.,
1991 [81]
25 <37 1790 ˘ 380 94 ˘ 18
25 >37 2800 ˘ 200 129 ˘ 14
10 >37 1880 ˘ 150 112 ˘ 9
Wasowicz et al.,
1993 [82]
51 >37 81 ˘ 24
51 <37 93 ˘ 12
23 1500–2499 85 ˘ 13
41 2500–4750 81 ˘ 27
13 24–36 92 ˘ 12
15 37–38 87 ˘ 33
36 39–41 78 ˘ 19
Iqbal et al., 2001
[83]
3 28–33 90 ˘ 47
29 34–36 88 ˘ 30
22 37–39 83 ˘ 39
11 40–41 79 ˘ 24
11 1000–1500 103 ˘ 37
16 1600–2000 81 ˘ 25
10 2100–2500 79 ˘ 29
18 2600–3000 83 ˘ 43
10 3100–4000 81 ˘ 14
Perveen et al.,
2002 [84]
11 24–28 116 ˘ 45
11 29–33 94 ˘ 19
9 34–37 89 ˘ 15
11 38–42 87 ˘ 9
Galinier et al.,
2005 [85]
53 26–31 160 ˘ 27
76 31–33 137 ˘ 30
66 33–34 125 ˘ 23
53 34–37 128 ˘ 18
262 >37 3234 ˘ 358 123 ˘ 20
Tsuzuki et al.,
2013 [86]
14 36 ˘ 2 2388 ˘ 465 89 ˘ 14
30 39 ˘ 1 3043 ˘ 321 86 ˘ 16
6. Zinc Deficiency and Neonatal Complications
Typical signs of zinc deficiency in newborns include dermatitis and growth impairment [88,89].
However, the zinc status in the first weeks of life may influence the occurrence of many other
pathological conditions interfering with their crucial pathogenic steps.
6.1. Dermatitis
Rash is the most common clinical feature of zinc deficiency, often misdiagnosed as Candida,
eczema, or impetigo [88,90]. In preterm infants, the characteristic skin changes may occur early
in the anterior neck fold, with poorly marginated erythema in the depth of the fold, that becomes
well demarcated and scaled within five days [80,88,90]. Deficient patients respond quickly to oral
zinc supplementation, usually within one week [91]. Many of the skin lesions observed in preterm
neonates after the first week of life may depend on a zinc deficiency [51–92]. Thus, evaluation
of zinc status is recommended in the newborn with dermatologic manifestation that cannot be
explained otherwise.
6.2. Growth Retardation
Zinc intake has been associated with growth outcomes in both term and preterm infants over
the first 12 months [51,93]. It seems clear that very preterm infants, who have poor zinc stores and
great need for growth, are at particular risk of zinc deficiency, as shown by Ram Kumar et al. [94].
Itabashi et al. demonstrated an increased risk of low serum zinc levels with higher weight gain [95].
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This phenomenon could be due to the increased enzyme activity and protein synthesis associated
with growth. Zinc is a key element in the synthesis of proteins essential for growth [96]. Neonates
with improved growth have greater zinc requirements and, consequently, present a higher risk of
nutritional deficiency. However, this hypothesis remains, at present, still uninvestigated. On the other
hand, zinc deficiency may limit neonatal growth; thus, its diagnosis should be considered for any
preterm infant who is not growing well despite an apparently adequate energy and macronutrient
intake, who has not consistently received a zinc-fortified human milk or formula designed for preterm
infants, who has sustained any gastrointestinal resection or insult, or is on diuretic therapy [50,51,97].
6.3. Necrotizing Enterocolitis
Necrotizing enterocolitis (NEC) is the most severe gastrointestinal emergency in neonates.
In some intensive care units, NEC affects up to 10% of premature infants [98]. The pathogenic
mechanisms of NEC are not yet completely understood. The combination of intestinal immaturity,
hemodynamic instability, asphyxia, infections and impaired inflammatory response underlies the
development of NEC [98]. Nutritional approach may significantly influence the risk of NEC [99].
Despite that the role of zinc in many intestinal functions and clinical conditions of children has
been widely studied, the clinical effects of zinc on the neonatal intestine remain largely unexplored.
Several experimental models and clinical evidences suggest a role for zinc in the pathogenesis of
NEC [87,100,101]. Zinc modulates the expression of important inflammatory cytokines and their
receptors in the intestine in models of colitis [102]. Subjects deficient in zinc showed a reduced
immune response against pathogens [103]. Zinc also has trophic effects on intestinal mucosa and
modulates intestinal permeability [104,105]. Finally, zinc deficiency worsens the extent of damage
from asphyxiation due to the reduced enzymatic antioxidant activities [106]. However, no systematic
study has been carried out so far on the possible role of zinc in the development of NEC. A multicenter
trial on premature babies reported a significant reduction in NEC incidence in subjects receiving high
doses of zinc [87]. Based on the above-mentioned evidence, it is reasonable to imagine a role for zinc
in NEC prevention, and design specific studies in this field.
6.4. Neurologic Damage
Zinc regulates the expression of neurotrophic factors that reduce apoptosis subsequent to
different types of insults and promote neuronal regeneration [107,108]. Very low birth weight babies
(VLBW) are at high risk of hypoxic brain damage. Severity of brain damage is influenced by the
activity of zinc-dependent metallothioneins [109]. In different models of hypoxia, brain lesions are
directly correlated with zinc concentrations in experimental conditions [110]. Zinc seems essential
also in the modulation of vascular tone at the cerebral level [111]. The reduced ability to control the
tone of cerebral vessels is of critical importance in the development of hypoxic-ischemic injury and
intraventricular hemorrhage in the preterm infant [108]. However, clinical trials on the role of zinc in
the prevention of brain damage in preterm neonate are not available at the moment.
6.5. Bronchopulmonary Dysplasia
Despite significant improvement in neonatal care and the consequent reduction in mortality
associated with respiratory complications, the incidence of bronchopulmonary dysplasia (BPD) has
remained unchanged over the years [112]. In the last two decades, clinical presentation of BPD has
varied significantly. New types of BPD, characterized by growth arrest of the respiratory tract or
by destructive lesions, usually occur in extremely preterm infants (gestational age <28 weeks, birth
weight <750 g), with little chance of survival until a few years ago [113]. In the new BPD, nutritional
support is essential to promote the development of the respiratory tract and prevent further
inflammatory damage deriving from mechanical ventilation and local or systemic infections [113].
For these reasons, prestigious scientific societies have recommended specific nutritional intakes for
the prevention of bronchopulmonary dysplasia (BPD) [114]. The action of antioxidant enzymes is
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essential to reduce the oxidative damage induced by mechanical ventilation, and the remodeling
action of metalloproteinase is essential in response to inflammatory damage [115]. Zinc promotes
epithelial development, participates in the enzymatic reactions underlying the repair of tissue
damage, protects against infection, and modulates the inflammatory response in the respiratory
system [116]. Thus, it is reasonable to hypothesize a role of zinc in preventing bronchopulmonary
dysplasia. However, clinical studies demonstrating a clear relationship between zinc and BPD are
not yet available.
6.6. Infections
It has been clearly demonstrated that zinc deficiency increases risk and severity of infections by
reducing immune response to pathogens [117]. Zinc is a crucial element of the immune response.
The presence of zinc is essential to ensure the normal activity of enzymes, peptides and cytokines
in the cells of immune system. This element stabilizes the membranes of immune cells by acting on
the cytoskeleton and regulates apoptosis, diapedesis and recruitment of immune cells. A wealth of
evidence and recent trials confirm the utility of zinc in the prevention and treatment of intestinal and
extra intestinal infections [117,118]. However, there is still no data available on the effectiveness of
zinc in preventing infectious diseases in preterm neonates.
6.7. Retinopathy of Prematurity
Retinopathy of prematurity (ROP) is a major cause of blindness worldwide [119]. ROP is induced
by multiple pathogenic phases. Exposure to high oxygen concentrations induces the cessation
of retinal vessel growth after premature birth, through the down-regulation of the expression of
growth factors essential for adequate retinal development (i.e., Vascular endothelial growth factor:
VEGF) [117]. The vascular depletion of the retina associated with body growth induces a state of
chronic hypoxia and exposes the retina to the continuous risk of ischemia, especially in critically ill
neonates [120]. Oxidative damage and inflammation, deriving from frequent ischemia-reperfusion
injury, leads to an abnormal proliferation of vessels and pathologic neovascularization [119]. Zinc
is the most abundant trace metal in the retina and may serve a critical function as antioxidant in
this tissue [20]. Zinc also induces synthesis of metallothioneins, zinc-ion-binding proteins with a
wide range of functions, including defense against oxidative damage and inflammation induced by
hypoxia [120]. The human eye is enriched in metallothioneins. These zinc-enzymes contribute to
antioxidant mechanisms of defense in the retina as in other ocular tissues [121]. It is possible to
hypothesize a role of zinc in the inhibition of neovascularization, not only by reducing oxidative
damage but also by controlling the expression of growth factors (i.e., VEGF). This issue may represent
a fascinating field of research for future studies.
Despite these plausible assumptions, trials in neonates have failed to demonstrate the efficacy of
antioxidants in preventing ROP. On the other hand, there is encouraging data from a trial on preterm
neonates demonstrating a trend to a reduction in ROP in subjects receiving high doses of zinc [87].
7. Supplementation of Zinc
Preterm infants are generally believed to be in a negative zinc balance within the first 4–8 weeks
of life, unless intakes are not bolstered by specific supplements [122]. Zinc could be provided through
parenteral nutrition support, or fortified human milk, formulas designed for premature infants,
or specific products containing zinc. Zinc-supplemented parenteral nutrition early in postnatal
life, followed by enteral administration of zinc in adequate doses, should aim to be sufficient to
meet zinc requirements also for extremely low birth weight infants (ELBW). Several indications
for zinc requirements are available (Table 7) [123–130]. Interestingly, recommended intakes have
progressively increased during the last decade. The recommended enteral intake ranges between
0.8 to 3 mg/Kg/day [3]. Zinc requirements for term infants are estimated to be 0.8 mg/day, whereas
preterm neonates may require up to 3 mg/kg per day to achieve adequate zinc retention [3]. Less
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variability regarding intravenous supplementation may be found in the recommendations of different
scientific societies and committees. Despite that only 60% of parenterally infused zinc is retained,
different authors suggest parenteral supplementation with 350 mcg/kg per day [51,131]. Recent
evidence supports the use of higher zinc doses to improve survival and reduce morbidity in VLBW
neonates [87]. Higher zinc supplementation is also justified if we consider that in the last trimester
of pregnancy the fetus receives up to 1 mg/Kg/day of zinc from the mother. Thus, to reach a similar
intake, 0.5–0.8 mg/Kg/day or 4–5 mg/Kg/day zinc should be administered by the parenteral or oral
route, respectively (Figure 4) [132,133]. However, further trials, including pharmacokinetic studies,
are advocated before modifying current recommendations on the use of zinc.
Zinc requirement in preterm neonates is quite similar to that of fetuses with similar
postconceptional age. However, a lower percentage of zinc administered in preterm neonates
by enteral or parenteral nutrition is retained. Thus, if zinc is provided according to current
recommendation (columns zinc intake), the final balance of zinc is negative, at variance with what
happens during fetal life, when zinc is transferred by the placenta, directly in the fetal circulation, at
a daily amount of about 900 mcg.
Table 7. Recommendations for zinc in neonates by enteral or parenteral route.
Institute/Scientific
Societies/Academic Groups
Publication
Year
Population of
Neonates Dose (mg/Kg/Day)
Enteral route
The American Academy of Pediatrics
Committee on nutrition [123] 1985 All 0.6
Committee on Nutrition of the Preterm
Infant, European Society of Paediatric
Gastroenterology and Nutrition [124]
1987 All 0.7–1.4
Zlotkin et al. [125] 1996
0–14 days of life 0.5–0.8
>14 day of life 1
Klein et al. [126] 2002
Birth weight <1 Kg 2
Birth weight 1–2 Kg 1.7
Birth weight >2 Kg 1.3
Hambidge et al. [127] 2006
Birth weight <1 Kg 2.4
Birth weight 1–2 Kg 2
Birth weight 2–3.5 Kg 1.6
ESPGHAN Committee on Nutrition [128] 2010 Birth weight <1.8 Kg 1.1–2.0
Griffin et al. [129] 2013
Human milk feed 2.3–2.4
Formula feed 1.8–2.4
Parenteral route
American Society of Clinical Nutrition [130] 1988 All 0.4
Zlotkin et al. [125] 1996
Transitional period 0.15
Stable period 0.4
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Figure 4. Zinc balance in fetal and neonatal life [132,133].
8. Excessive Exposure to Zinc
Zinc supplementation is generally safe. However, an excess of zinc (>20 mg/Kg/day) may
influence absorption and retention of other trace elements such as copper and vitamin A [50,74].
Zinc may induce copper deficiency by inhibiting the gastrointestinal absorption [134]. On the other
hand, copper supplementation boosts the conjugation of zinc with large molecules and depletes
the ratio of zinc coupled with smaller molecules, thereby suggesting an antagonism between the
transport of these two elements [135]. Indeed, no cases of hypocupremia have been described in
trials using zinc in neonates (with doses ranging from 2 to 10 mg/Kg/day) not even when copper
was not supplemented.
Zinc status influences vitamin A absorption, transport and utilization [74]. Evidence of an effect
of zinc intake on vitamin A status from animal experiments are inconclusive, mainly because of the
use of inadequate control groups [136]. Randomized trials in children have failed to show a consistent
effect of zinc supplementation on vitamin A status [137] and there is no such evidence in neonates. To
the best of our knowledge, none of the other potential consequences of zinc excess, such as cytopenias
or myeloneuropathy, has been reported in neonates.
9. Conclusions
Zinc plays a crucial role during the first phase of life, including embryogenesis and fetal life.
Preterm neonates continue their “fetal” development in an extra-uterine environment. Consequently,
zinc stores are not completed and its requirement increase in babies born prematurely. Considering
the large number of roles played by zinc in early life, the consequences of zinc deficiency in
preterm neonates are extremely variable and may be severe in many cases. A large percentage
of preterm neonates is affected by mild to moderate subclinical zinc deficiency. Diagnosis of zinc
deficiency, especially if of mild severity, is not easy due to its nonspecific features and to the lack
of highly sensitive biomarkers. On the other hand, early diagnosis may be essential to avoid severe
consequences of zinc deficiency. Clinical evaluation and research of the risk factors associated with
the measurement of serum level of zinc is the most appropriate approach in the diagnosis of zinc
deficiency. Dealing with the deficiency by zinc supplements is highly effective in neonates, with
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proven benefits on skin lesions and growth. Supplementation with adequate doses of zinc may
also reduce the occurrence and severity of the morbidities typical of prematurity. However, current
recommendations for zinc seem inadequate to meet the requirement of extremely preterm neonates
and should be revised.
Despite the consistent number of articles on the role of zinc in early life, many interesting aspects
remain to be clarified. Possible area of future research may be summarized in ten issues:
1. Study of the role of zinc in infertility and multiple abortions
2. Identification of diet and environmental determinants of zinc absorption in otherwise
well-nourished pregnant women
3. Evaluation of zinc metabolism in neonates with alcoholic syndrome
4. Definition of determinants of zinc absorption in preterm neonates
5. Calculation of diagnostic power of zinc concentration assessment in cells and hairs, and of
metalloenzyme in preterm neonates
6. Definition of modalities for zinc supplementation in preterm neonates (doses, administration
route, duration of therapy)
7. Evaluation of the usefulness of individualized zinc supplementation in human milk feeding for
preterm neonates
8. Study of the relation between zinc and vitamin A in preterm neonates
9. Study of the relation between zinc deficiency and occurrence of morbidities (i.e., NEC, brain
damage, BPD, infectious diseases, ROP) in preterm neonates.
10. Determination of zinc efficacy in reducing severe complications of prematurity and the study of
the related mechanisms
When such data become available, the role of zinc in early life will be further clarified and the use
of zinc in neonates could be optimized. Considering the critical role of zinc in neonatal life, research
in this field is widely advocated.
Author Contributions: G.T., R.B.C. and M.De.C. wrote the first draft of the manuscript, to which M.Di.C., A.P.
and F.C. contributed. G.T., M.Di.C., A.P., F.C. and V.A. revised with evidence available in the literature. All
authors contributed to the final draft of the manuscript.
Conflicts of Interest: The authors declare no conflict of interest.
References
1. King, J.C. Zinc: An Essential but Elusive Nutrient. Am. J. Clin. Nutr. 2011, 94, 679S–684S. [CrossRef]
[PubMed]
2. Vallee, B.L.; Auld, D.S. Zinc Coordination, Function, and Structure of Zinc Enzymes and Other Proteins.
Biochemistry 1990, 19, 5647–5659. [CrossRef]
3. Hambidge, K.M.; Krebs, N.F. Zinc in the Fetus and Neonate. In Fetal Neonatal Physiol; Elsevier Saunders:
Philadelphia, PA, USA, 2004; pp. 342–347.
4. Vallee, B.L.; Auld, D.S. Active Zinc Binding Sites of Zinc Metalloenzymes. Matrix Suppl. 1992, 1, 5–19.
[PubMed]
5. Palmiter, R.D. The Elusive Function of Metallothioneins. Proc. Natl. Acad. Sci. USA 1998, 21, 8428–8430.
[CrossRef]
6. Hijova, E. Metallothioneins and zinc: Their functions and interactions. Bratisl. Lek. Listy 2004, 105, 230–234.
[PubMed]
7. Hanas, J.S.; Hazuda, D.J.; Bogenhagen, D.F.; Wu, F.Y.; Wu, C.W. Xenopus Transcription factor a requires
zinc for binding to the 5 S RNA gene. J. Biol. Chem. 1983, 10, 14120–14125.
8. Miller, J.; McLachlan, A.D.; Klug, A. Repetitive zinc-binding domains in the protein transcription factor
IIIA from Xenopus oocytes. EMBO J. 1985, 4, 1609–1614. [PubMed]
9. Shang, Z.; Liao, Y.D.; Wu, F.Y.; Wu, C.W. Zinc Release from Xenopus transcription factor IIIA induced by
chemical modifications. Biochemistry 1989, 12, 9790–9795. [CrossRef]
10440
Nutrients 2015, 7, 10427–10446
10. Evans, R.M. The steroid and thyroid hormone receptor superfamily. Science 1988, 13, 889–895. [CrossRef]
11. Fukada, T.; Yamasaki, S.; Nishida, K.; Murakami, M.; Hirano, T. Zinc homeostasis and signaling in health
and diseases: Zinc signaling. J. Biol. Inorg. Chem. 2011, 16, 1123–1134. [CrossRef] [PubMed]
12. Prasad, A.S. Zinc in human health: Effect of zinc on immune cells. Mol. Med. 2008, 14, 353–357. [CrossRef]
[PubMed]
13. Prasad, A.S.; Meftah, S.; Abdallah, J.; Kaplan, J.; Brewer, G.J.; Bach, J.F.; Dardenne, M. Serum thymulin in
human zinc deficiency. J. Clin. Investig. 1988, 82, 1202–1210. [CrossRef] [PubMed]
14. Summersgill, H.; England, H.; Lopez-Castejon, G.; Lawrence, C.B.; Luheshi, N.M.; Pahle, J.; Mendes, P.;
Brough, D. Zinc depletion regulates the processing and secretion of IL-1β. Cell Death Dis. 2014, 30, e1040.
[CrossRef] [PubMed]
15. Grahn, B.H.; Paterson, P.G.; Gottschall-Pass, K.T.; Zhang, Z. Zinc and the eye. J. Am. Coll. Nutr. 2001, 20,
106–118. [CrossRef] [PubMed]
16. MacDonald, R.S. The Role of Zinc in Growth and Cell Proliferation. J. Nutr. 2000, 130, 1500S–1508S.
[PubMed]
17. Bobat, R.; Coovadia, H.; Stephen, C.; Naidoo, K.L.; McKerrow, N.; Black, R.E.; Moss, W.J. Safety and Efficacy
of Zinc Supplementation for Children with HIV-1 Infection in South Africa: A randomised double-blind
placebo-controlled trial. Lancet 2005, 366, 1862–1867. [CrossRef]
18. Wastney, M.E.; Angelus, P.A.; Barnes, R.M.; Subramanian, K.N. Zinc absorption, distribution, excretion,
and retention by healthy preterm infants. Pediatr. Res. 1999, 45, 191. [CrossRef] [PubMed]
19. Zlotkin, S.H.; Cherian, M.G. Hepatic Metallothionein as a Source of Zinc and Cysteine during the First Year
of Life. Pediatr. Res. 1988, 24, 326–329. [CrossRef] [PubMed]
20. Falchuk, K.H. The Molecular Basis for the Role of Zinc in Developmental Biology. Mol. Cell Biochem. 1998,
188, 41–48. [CrossRef] [PubMed]
21. Record, I.R. Zinc Deficiency and the Developing Embryo. Neurotoxicology 1987, 8, 369–378. [PubMed]
22. Simmer, K.; Lort-Phillips, L.; James, C.; Thompson, R.P. A Double-blind Trial of Zinc Supplementation in
Pregnancy. Eur. J. Clin. Nutr. 1991, 45, 139–144. [PubMed]
23. Hambidge, K.M.; Hackshaw, A. Neural Tube Defects and Serum Zinc. Br. J. Obstet. Gynaecol. 1993, 100,
746–749. [CrossRef] [PubMed]
24. Keen, C.L.; Hurley, L.S.; Lönnerdal, B. Effects of Zinc Deficiency on Prenatal and Postnatal Development.
Fed. Proc. 1987, 42, 1735–1739.
25. Hurley, L.S. Zinc Deficiency in the Developing Rats. Am. J. Clin. Nutr. 1969, 22, 1332–1339. [PubMed]
26. Hickory, W.; Nanda, R.; Catalanotto, F.A. Fetal Skeletal Malformations Associated with Moderate Zinc
Deficiency during Pregnancy. J. Nutr. 1979, 109, 883–891. [PubMed]
27. Rogers, J.M.; Keen, C.L.; Hurley, L.S. Zinc Deficiency in Pregnant Long-Evans Hooded Rats: Teratogenicity
and Tissue Trace Elements. Teratology 1985, 31, 89–100. [CrossRef] [PubMed]
28. Falchuk, K.H.; Montorzi, M. Zinc Physiology and Biochemistry in Oocytes and Embryos. Biometals 2001,
14, 385–395. [CrossRef] [PubMed]
29. Velie, E.M.; Block, G.; Shaw, G.M.; Samuels, S.J.; Schaffer, D.M.; Kulldorff, M. Maternal Supplemental and
Dietary Zinc and the Occurrence of Neural Tube Defects in California. Am. J. Epidemiol. 1999, 150, 605–616.
[CrossRef] [PubMed]
30. Cengiz, B.; Söylemez, F.; Oztürk, E.; Cavdar, A.O. Serum Zinc, Selenium, Copper, and Lead Levels in
Women with Second-Trimester Induced Abortion Resulting from Neural Tube Defects: A Preliminary
Study. Biol. Trace Elem. Res. 2004, 97, 225–235. [CrossRef]
31. Zeyrek, D.; Soran, M.; Cakmak, A.; Kocyigit, A.; Iscan, A. Serum Copper and Zinc Levels in Mothers and
Cord Blood of Their Newborn Infants with Neural Tube Defects: A Case-control Study. Indian Pediatr. 2009,
46, 675–680. [PubMed]
32. Dey, A.C.; Shahidullah, M.; Mannan, M.A.; Noor, M.K.; Saha, L.; Rahman, S.A. Maternal and Neonatal
Serum Zinc Level and its Relationship with Neural Tube Defects. J. Health Popul. Nutr. 2010, 28, 343–350.
[CrossRef] [PubMed]
33. Masters, D.G.; Keen, C.L.; Lönnerdal, B.; Hurley, L.S. Zinc deficiency teratogenicity: The protective role of
maternal tissue catabolism. J. Nutr. 1983, 113, 905–912. [PubMed]
34. Miller, S.I.; del Villano, B.C.; Flynn, A.; Krumhansl, M. Interaction of alcohol and zinc in fetal
dysmorphogenesis. Pharmacol. Biochem. Behav. 1983, 18, 311–315. [CrossRef]
10441
Nutrients 2015, 7, 10427–10446
35. Zidenberg-Cherr, S.; Rosenbaum, J.; Keen, C.L. Influence of ethanol consumption on maternal-fetal transfer
of zinc in pregnant rats on day 14 of pregnancy. J. Nutr. 1988, 118, 865–870. [PubMed]
36. Da Cunha Ferreira, R.M.; Marquiegui, I.M.; Elizaga, I.V. Teratogenicity of zinc deficiency in the rat: Study
of the fetal skeleton. Teratology 1989, 39, 181–194. [CrossRef] [PubMed]
37. Keen, C.L.; Uriu-Adams, J.Y.; Skalny, A.; Grabeklis, A.; Grabeklis, S.; Green, K.; Yevtushok, L.;
Wertelecki, W.W.; Chambers, C.D. The Plausibility of Maternal Nutritional Status Being a Contributing
Factor to the Risk for Fetal Alcohol Spectrum Disorders the Potential Influence of Zinc Status as an Example.
Biofactors 2010, 36, 125–135. [CrossRef] [PubMed]
38. Keppen, L.D.; Pysher, T.; Rennert, O.M. Zinc Deficiency Acts as a Co-teratogen with Alcohol in Fetal
Alcohol Syndrome. Pediatr. Res. 1985, 19, 944–947. [CrossRef] [PubMed]
39. McClain, C.J.; Kasarskis, E.J., Jr.; Allen, J.J. Functional Consequences of Zinc Deficiency. Prog. Food Nutr.
Sci. 1985, 9, 185–226. [PubMed]
40. Wastney, M.E.; Angelus, P.; Barnes, R.M.; Subramanian, K.N. Zinc Kinetics in Preterm Infants: A
Compartmental Model Based on Stable Isotope Data. Am. J. Physiol. 1996, 271, 1452–1459.
41. Donangelo, C.M.; King, J.C. Maternal Zinc Intakes and Homeostatic Adjustments during Pregnancy and
Lactation. Nutrients 2012, 4, 782–798. [CrossRef] [PubMed]
42. Bax, C.M.; Bloxam, D.L. Two Major Pathways of Zinc (II) Acquisition by Human Placental
Syncytiotrophoblast. J. Cell. Physiol. 1995, 164, 546–554. [CrossRef] [PubMed]
43. Ota, E.; Mori, R.; Middleton, P.; Tobe-Gai, R.; Mahomed, K.; Miyazaki, C.; Bhutta, Z.A. Zinc
supplementation for improving pregnancy and infant outcome. Cochrane Database Syst. Rev. 2015, 2, 10.
44. Goldenberg, R.L.; Tamura, T.; Neggers, Y.; Copper, R.L.; Johnston, K.E.; DuBard, M.B.; Hauth, J.C. The
Effect of Zinc Supplementation on Pregnancy Outcome. JAMA 1995, 9, 463–468. [CrossRef]
45. King, J.C. Determinants of Maternal Zinc Status during Pregnancy. Am. J. Clin. Nutr. 2000, 71, 1334S–1343S.
[PubMed]
46. Sandstead, H.H.; Freeland-Graves, J.H. Dietary Phytate, Zinc and Hidden Zinc Deficiency. J. Trace Elem.
Med. Biol. 2014, 28, 414–417. [CrossRef] [PubMed]
47. Hambidge, K.M.; Miller, L.V.; Westcott, J.E.; Krebs, N.F. Dietary Reference Intakes for Zinc may Require
Adjustment for Phytate Intake Based upon Model Predictions. J. Nutr. 2008, 138, 2363–2366. [CrossRef]
[PubMed]
48. Sur, D.; Gupta, D.N.; Mondal, S.K.; Ghosh, S.; Manna, B.; Rajendran, K.; Bhattacharya, S.K. Impact of Zinc
Supplementation on Dhiarroeal Morbidity and Growth Pattern of Low Birth Weight Infants in Kolkata
India: A randomized, double-blind, placebo-controlled, community-based study. Pediatrics 2003, 112,
1327–1332. [CrossRef] [PubMed]
49. Wulf, K.; Wilhelm, A.; Spielmann, M.; Wirth, S.; Jenke, A.C. Frequency of Symptomatic Zinc Deficiency in
very Low Birth Weight Infants. Klin. Padiatr. 2013, 225, 13–17. [CrossRef] [PubMed]
50. Hemalatha, P.; Bhaskaram, P.; Kumar, P.A.; Khan, M.M.; Islam, M.A. Zinc Status of Breastfed and
Formula-fed Infants of Different Gestational Ages. J. Trop. Pediatr. 1997, 43, 52–54. [CrossRef] [PubMed]
51. Giles, E.; Doyle, L.W. Zinc in extremely Low-Birthweight or Very Preterm Infants. Neoreviews 2007, 8,
e165–e172. [CrossRef]
52. Picciano, M.F.; Guthrie, H.A. Copper, Iron, and Zinc Contents of Mature Human Milk. Am. J. Clin. Nutr.
1976, 29, 242–254. [PubMed]
53. Walravens, P.A.; Chakar, A.; Mokni, R.; Denise, J.; Lemonnier, D. Zinc supplements in breastfed infants.
Lancet 1992, 9, 683–685. [CrossRef]
54. Castillo-Durán, C.; Rodríguez, A.; Venegas, G.; Alvarez, P.; Icaza, G. Zinc supplementation and growth of
infants born small for gestational age. J. Pediatr. 1995, 127, 206–211. [CrossRef]
55. Ehrenkranz, R.A.; Gettner, P.A.; Nelli, C.M.; Sherwonit, E.A.; Williams, J.E.; Ting, B.T.; Janghorbani, M. Zinc
and Copper Nutritional Studies in very Low Birth Weight Infants: Comparison of stable isotopic extrinsic
tag and chemical balance. Pediatr. Res. 1989, 26, 298–307. [CrossRef] [PubMed]
56. Passariello, A.; Terrin, G.; Baldassarre, M.E.; de Curtis, M.; Paludetto, R.; Berni Canani, R. Diarrhea in
neonatal intensive care unit. World J. Gastroenterol. 2010, 7, 2664–2668. [CrossRef]
57. Dauncey, M.J.; Shaw, J.C.; Urman, J. The Absorption and Retention of Magnesium, Zinc and Copper by
Low Birth Weight Infants Fed Pasteurized Human Breast Milk. Pediatr. Res. 1977, 11, 1033–1039. [CrossRef]
[PubMed]
10442
Nutrients 2015, 7, 10427–10446
58. Shaw, J.C. Trace elements in the Fetus and Young Infant. I. Zinc. Am. J. Dis. Child. 1979, 133, 1260–1268.
[CrossRef] [PubMed]
59. Gibson, R.S.; Dewolfe, M.S. Changes in Serum Zinc Concentrations of Some Canadian Full Term and Low
Birthweight Infants from Birth to Six Months. Acta Paedtr. 1981, 70, 497–500. [CrossRef]
60. Tyrala, E.E.; Manser, J.I.; Brodsky, N.L.; Tran, N. Serum Zinc Concentrations in Growing Premature Infants.
Acta Paediatr. Scand. 1983, 72, 695–698. [CrossRef] [PubMed]
61. McMaster, D.; Lappin, T.R.; Halliday, H.L.; Patterson, C.C. Serum Copper and Zinc Levels in the Preterm
Infant. A longitudinal Study of the First Year of Life. Biol. Neonate. 1983, 44, 108–113. [CrossRef] [PubMed]
62. Kelleher, S.L.; Lönnerdal, B. Zinc transporters in the rat mammary gland respond to marginal zinc and
vitamin A intakes during lactation. J. Nutr. 2002, 132, 3280–3285. [PubMed]
63. Kumar, L.; Michalczyk, A.; McKay, J.; Ford, D.; Kambe, T.; Hudek, L.; Varigios, G.; Taylor, P.E.;
Ackland, M.L. Altered Expression of Two Zinc Transporters, SLC30A5 and SLC30A6underlies a Mammary
Gland Disorder of Reduced Zinc Secretion into Milk. Genes Nutr. 2015, 10, 38. [CrossRef] [PubMed]
64. Sandström, B.; Cederblad, A. Zinc Absorption from Composite Meals. II. Influence of the main protein
source. Am. J. Clin. Nutr. 1980, 33, 1778–1783. [PubMed]
65. Snedeker, S.M.; Greger, J.L. Metabolism of Zinc, Copper and Iron as affected by Dietary Protein, Cysteine
and histidine. J. Nutr. 1983, 113, 644–652. [PubMed]
66. Sandström, B.; Almgren, A.; Kivistö, B.; Cederblad, A. Effect of Protein Level and Protein Source on Zinc
Absorption in Humans. J. Nutr. 1989, 119, 48–53. [PubMed]
67. Hurrell, R.F.; Lynch, S.R.; Trinidad, T.P.; Dassenko, S.A.; Cook, J.D. Iron Absorption in Humans as
Influenced by Bovine Milk Proteins. Am. J. Clin. Nutr. 1989, 49, 546–552. [PubMed]
68. Sandström, B.; Sandberg, A.S. Inhibitory Effects of Isolated Inositol Phosphates on Zinc Absorption in
Humans. J. Trace Elem. Electrolytes Health. Dis. 1992, 6, 99–103. [PubMed]
69. Voyer, M.; Davakis, M.; Antener, I.; Valleur, D. Zinc Balances in Preterm Infants. Biol. Neonate 1982, 42,
87–92. [CrossRef] [PubMed]
70. August, D.; Janghorbani, M.; Young, V.R. Determination of Zinc and Copper Absorption at Three Dietary
Zn-Cu by Using Stable Isotope Methods in Young Adult and Elderly Subjects. Am. J. Clin. Nutr. 1989, 50,
1457–1463. [PubMed]
71. Sandström, B.; Davidsson, L.; Cederblad, A.; Lönnerdal, B. Oral iron, Dietary Ligands and Zinc Absorption.
J. Nutr. 1985, 115, 411–414. [PubMed]
72. Christian, P.; Shahid, F.; Rizvi, A.; Klemm, R.D.; Bhutta, Z.A. Treatment Response to Standard of Care for
Severe Anemia in Pregnant Women and Effect of Multivitamins and Enhanced Anthelminthics. Am. J. Clin.
Nutr. 2009, 89, 853–861. [CrossRef] [PubMed]
73. Milne, D.B.; Canfield, W.K.; Mahalko, J.R.; Sandstead, H.H. Effect of Oral Folic Acid Supplements on Zinc,
Copper, and Iron Absorption and Excretion. Am. J. Clin. Nutr. 1984, 39, 535–539. [PubMed]
74. Smith, J.C., Jr.; Brown, E.D.; McDaniel, E.G.; Chan, W. Alterations in Vitamin A Metabolism during Zinc
Deficiency and Food and Growth Restriction. J. Nutr. 1976, 106, 569–574. [PubMed]
75. Christian, P.; West, K.P., Jr. Interactions between Zinc and Vitamin A: An update. Am. J. Clin. Nutr. 1998,
68, 435S–441S. [PubMed]
76. Gibson, R.S.; Hess, S.Y.; Hotz, C.; Brown, K.H. Indicators of Zinc Status at the Population Level: A review
of the evidence. Br. J. Nutr. 2008, 99, S14–23. [CrossRef] [PubMed]
77. Thompson, R.P. Assessment of Zinc Status. Proc. Nutr. Soc. 1991, 50, 19–28. [CrossRef] [PubMed]
78. King, J.C. Assessment of Zinc Status. J. Nutr. 1990, 120, 1474–1479. [PubMed]
79. Hambidge, K.M. Hair Analyses: Worthless for vitamins, limited for minerals. Am. J. Clin. Nutr. 1982, 36,
943–949. [PubMed]
80. Hambidge, K. Copper. In Neonatal Nutrition and Metabolism, 2nd ed.; Thureen, P., Hay, W., Jr., Eds.;
Cambridge University Press: Cambridge, UK, 2006; pp. 281–292.
81. Jeswani, R.M.; Vani, S.N. A study of Serum Zinc Levels in Cord Blood of Neonates and their Mothers.
Indian J. Pediatr. 1991, 58, 683–686. [CrossRef] [PubMed]
82. Wasowicz, W.; Wolkanin, P.; Bednarski, M.; Gromadzinska, J.; Sklodowska, M.; Grzybowska, K. Plasma
trace element (Se, Zn, Cu) concentrations in maternal and umbilical cord blood in Poland. Relation with
birth weight, gestational age, and parity. Biol. Trace Elem. Res. 1993, 38, 205–215. [CrossRef] [PubMed]
10443
Nutrients 2015, 7, 10427–10446
83. Iqbal, A.S.; Shahidullah, M.; Islam, M.N.; Akhter, S.; Banu, S. Serum Zinc and Copper Levels in the Maternal
Blood and Cord Blood of Neonates. Indian J. Pediatr. 2001, 68, 523–526. [CrossRef] [PubMed]
84. Perveen, S.; Altaf, W.; Vohra, N.; Bautista, M.L.; Harper, R.G.; Wapnir, R.A. Effect of Gestational Age on
Cord Blood Plasma Copper, Zinc, Magnesium and Albumin. Early Hum. Dev. 2002, 69, 15–23. [CrossRef]
85. Galinier, A.; Périquet, B.; Lambert, W.; Garcia, J.; Assouline, C.; Rolland, M.; Thouvenot, J.P. Reference
Range for Micronutrients and Nutritional Marker Proteins in Cord Blood of Neonates Appropriated for
Gestational Ages. Early Hum. Dev. 2005, 81, 583–593. [CrossRef] [PubMed]
86. Tsuzuki, S.; Morimoto, N.; Hosokawa, S.; Matsushita, T. Associations of Maternal and Neonatal Serum
Trace Element Concentrations with Neonatal Birth Weight. PLoS ONE 2013, 27, e75627. [CrossRef]
[PubMed]
87. Terrin, G.; Berni Canani, R.; Passariello, A.; Messina, F.; Conti, M.G.; Caoci, S.; Smaldore, A.; Bertino, E.;
de Curtis, M. Zinc supplementation reduces morbidity and mortality in very-low-birth-weight preterm
neonates: A hospital-based randomized, placebo-controlled trial in an industrialized country. Am. J. Clin.
Nutr. 2013, 98, 1468–1474. [CrossRef] [PubMed]
88. Arlette, J.P.; Johnston, M.M. Zinc Deficiency Dermatosis in Premature Infants Receiving Prolonged
Parenteral Alimentation. J. Am. Acad. Dermatol. 1981, 5, 37–42. [CrossRef]
89. Islam, M.N.; Chowdhury, A.K.; Siddika, M.; Hossain, M.A.; Hossain, M.K. Effect of Zinc on Growth of
Preterm Babies. Mymensingh Med. J. 2009, 18, 125–130. [PubMed]
90. Prasad, A.S. Zinc Deficiency in Human Subjects. Prog. Clin. Biol. Res. 1983, 129, 1–33. [PubMed]
91. Zattra, E.; Belloni Fortina, A. Transient Symptomatic Zinc Deficiency Resembling Acrodermatitis
Enteropathica in a Breast-fed Premature Infant: Case report and brief review of the literature. G. Ital.
Dermatol. Venereol. 2013, 148, 699–702. [PubMed]
92. Perafán-Riveros, C.; França, L.F.; Alves, A.C.; Sanches, J.A., Jr. Acrodermatitis Enteropathica: Case report
and review of the literature. Pediatr. Dermatol. 2002, 19, 426–431. [CrossRef] [PubMed]
93. Islam, M.N.; Chowdhury, M.A.; Siddika, M.; Qurishi, S.B.; Bhuiyan, M.K.; Hoque, M.M.; Akhter, S. Effect of
Oral Zinc Supplementation on the Growth of Preterm Infants. Indian Pediatr. 2010, 47, 845–849. [CrossRef]
[PubMed]
94. Ram Kumar, T.V.; Ramji, S. Effect of Zinc Supplementation on Growth in very Low Birth Weight Infants. J.
Trop. Pediatr. 2012, 58, 50–54. [CrossRef] [PubMed]
95. Itabashi, K.; Saito, T.; Ogawa, Y.; Uetani, Y. Incidence and Predicting Factors of Hypozincemia in
very-low-birth-weight Infants at Near-term Postmenstrual Age. Biol. Neonate 2003, 83, 235–240. [CrossRef]
[PubMed]
96. Golden, B.E.; Golden, M.H. Effect of Zinc on Lean Tissue Synthesis during Recovery from Malnutrition.
Eur. J. Clin. Nutr. 1992, 46, 697–706. [PubMed]
97. Laureano, A.; Brás, S.; Carvalho, R.; Amaro, C.; Cardoso, J. Transient Symptomatic Zinc Deficiency in a
Preterm Exclusively Breast-fed Infant. Dermatol. Online J. 2014, 20, 14.
98. Terrin, G.; Scipione, A.; de Curtis, M. Update in Pathogenesis and Prospective in Treatment of Necrotizing
Enterocolitis. Biomed. Res. 2014, 2014, 543765. [CrossRef] [PubMed]
99. Terrin, G.; Passariello, A.; Canani, R.B.; Manguso, F.; Paludetto, R.; Cascioli, C. Minimal enteral feeding
reduces the risk of sepsis in feed-intolerant very low birth weight newborns. Acta Pediatr. 2009, 98, 31–35.
[CrossRef] [PubMed]
100. Harper, J.I.; Thompson, D.; Kovar, I.Z.; Copeman, P.W.; Barltrop, D. Zinc Deficiency in a Preterm Neonate
with Necrotizing Enterocolitis. J. R. Soc. Med. 1984, 77, 40–41. [PubMed]
101. Suwendi, E.; Iwaya, H.; Lee, J.S.; Hara, H.; Ishizuka, S. Zinc Deficiency Induces Dysregulation of Cytokine
Productions in an Experimental Colitis of Rats. Biomed. Res. 2012, 33, 329–336. [CrossRef] [PubMed]
102. De Queiroz, C.A.; Fonseca, S.G.; Frota, P.B.; Figueiredo, I.L.; Aragão, K.S.; Magalhães CEde Carvalho, C.B.;
Lima, A.Â.; Ribeiro, R.A.; Guerrant, R.L.; Moore, S.R.; et al. Zinc Treatment Ameliorates Diarrhea and
Intestinal Inflammation in Undernourished Rats. BMC Gastroenterol. 2014, 5, 136. [CrossRef] [PubMed]
103. Bolick, D.T.; Kolling, G.L.; Moore, J.H., 2nd; de Oliveira, L.A.; Tung, K.; Philipson, C.; Viladomiu, M.;
Hontecillas, R.; Bassaganya-Riera, J.; Guerrant, R.L. Zinc Deficiency Alters Host Response and Pathogen
Virulence in a Mouse Model of Enteroaggregative Escherichia coli-induced Diarrhea. Gut Microbes 2014, 5,
618–627. [CrossRef] [PubMed]
10444
Nutrients 2015, 7, 10427–10446
104. Vallee, B.L.; Falchuk, K.H. The Biochemical Basis of Zinc Pphysiology. Physiol. Rev. 1993, 73, 79–118.
[PubMed]
105. Berni Canani, R.; Secondo, A.; Passariello, A.; Buccigrossi, V.; Canzoniero, L.M.; Ruotolo, S.; Puzone, C.;
Porcaro, F.; Pensa, M.; Braucci, A.; et al. Zinc Inhibits Calcium-mediated and Nitric Oxide-mediated ion
Secretion in Human Enterocytes. Eur. J. Pharmacol. 2010, 25, 266–270. [CrossRef] [PubMed]
106. Kloubert, V.; Rink, L. Zinc as a Micronutrient and its Preventive Role of Oxidative Damage in cells. Food
Funct. 2015, 6, 3195–3204. [CrossRef] [PubMed]
107. Howell, G.A.; Welch, M.G.; Frederickson, C.J. Stimulation-induced Uptake and Release of Zinc in
Hippocampal Slices. Nature 1984, 308, 736–738. [CrossRef] [PubMed]
108. Frederickson, C.J.; Koh, J.Y.; Bush, A.I. The Neurobiology of Zinc in Health and Disease. Nat Rev. Neurosci.
2005, 6, 449–462. [CrossRef] [PubMed]
109. Adamo, A.M.; Oteiza, P.I. Zinc Deficiency and Neurodevelopment: The case of neurons. Biofactors 2010, 36,
117–124. [CrossRef] [PubMed]
110. Ho, E.; Ames, B.N. Low Intracellular Zinc Induces Oxidative DNA Damage, Disrupts p53, NFkappa B, and
AP1 DNA binding, and affects DNA Repair in a Rat Glioma Cell Line. Proc. Natl. Acad. Sci. USA 2002, 99,
16770–16775. [CrossRef] [PubMed]
111. Ramel, S.E.; Georgieff, M.K. Preterm Nutrition and the Brain. World Rev. Nutr. Diet. 2014, 110, 190–200.
[PubMed]
112. Zysman-Colman, Z.; Tremblay, G.M.; Bandeali, S.; Landry, J.S. Bronchopulmonary Dysplasia—Trends over
three decades. Paediatr. Child. Health 2013, 18, 86–90. [PubMed]
113. Merritt, T.A.; Deming, D.D.; Boynton, B.R. The “new” bronchopulmonary dysplasia challenges and
commentary. Semin. Fetal Neonatal. Med. 2009, 14, 345–357. [CrossRef] [PubMed]
114. Biniwale, M.A.; Ehrenkranz, R.A. The Role of Nutrition in The Prevention and Management of
Bronchopulmonary Dysplasia. Semin. Perinatol. 2006, 30, 200–208. [CrossRef] [PubMed]
115. Prasad, A.S. Zinc is an Antioxidant and Anti-Inflammatory Agent: Its Role in Human Health. Front. Nutr.
2014, 1, 14. [CrossRef] [PubMed]
116. Wu, W.; Bromberg, P.A.; Samet, J.M. Zinc ions as effectors of environmental oxidative lung injury. Free
Radic. Biol. Med. 2013, 65, 57–69. [CrossRef] [PubMed]
117. Bonaventura, P.; Benedetti, G.; Albarède, F.; Miossec, P. Zinc and its Role in Immunity and Inflammation.
Autoimmun. Rev. 2015, 14, 277–285. [CrossRef] [PubMed]
118. McDonald, C.M.; Manji, K.P.; Kisenge, R.; Aboud, S.; Spiegelman, D.; Fawzi, W.W.; Duggan, C.P. Daily Zinc
but Not Multivitamin Supplementation Reduces Diarrhea and Upper Respiratory Infections in Tanzanian
Infants: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. J. Nutr. 2015, 145, 2153–2160.
[CrossRef] [PubMed]
119. Beligere, N.; Perumalswamy, V.; Tandon, M.; Mittal, A.; Floora, J.; Vijayakumar, B.; Miller, M.T. Retinopathy
of Prematurity and Neurodevelopmental Disabilities in Premature Infants. Semin. Fetal Neonatal. Med.
2015, 20, 346–353. [CrossRef] [PubMed]
120. Li, S.Y.; Fu, Z.J.; Lo, A.C. Hypoxia-induced Oxidative Stress in Ischemic Retinopathy. Oxid. Med. Cell.
Longev. 2012, 2012. [CrossRef] [PubMed]
121. Yang, H.; Ding, Y.; Chen, L. Effect of Trace Elements on Retinopathy of Prematurity. J. Huazhong. Univ. Sci.
Technolog. Med. Sci. 2007, 27, 590–592. [CrossRef] [PubMed]
122. Caulfield, L.E.; Zavaleta, N.; Shankar, A.H.; Merialdi, M. Potential Contribution of Maternal Zinc
Supplementation during Pregnancy to Maternal and Child Survival. J. Clin. Nutr. 1998, 68, 499S–508S.
123. Anonymous. American Academy of Pediatrics Committee on Nutrition: Nutritional Needs of
Low-birth-weight infants. Pediatrics 1985, 75, 976–986.
124. Committee on Nutrition of the Preterm Infant; European Society of Paediatric Gastroenterology and
Nutrition. Nutrition and Feeding of Preterm Infants. Acta Paediatr. Scand. Suppl. 1987, 336, 1–14.
125. Zlotkin, S.H.; Atkinson, S.; Lockitch, G. Trace Elements in Nutrition for Premature Infants. Clin. Perinatol.
1996, 22, 223–240.
126. Klein, C.J. Nutrient requirements for preterm infant formulas. J. Nutr. 2002, 132, 1395S–1577S. [PubMed]
127. Hambidge, K.M.; Krebs, N.F.; Westcott, J.E.; Miller, L.V. Changes in Zinc Absorption during Development.
J. Pediatr. 2006, 149, S64–S68. [CrossRef] [PubMed]
10445
Nutrients 2015, 7, 10427–10446
128. Agostoni, C.; Buonocore, G.; Carnielli, V.P.; de Curtis, M.; Darmaun, D.; Decsi TDomellöf, M.;
Embleton, N.D.; Fusch, C.; Genzel-Boroviczeny, O.; Goulet, O.; et al. Enteral nutrient supply for preterm
infants: Commentary from the European Society of Paediatric Gastroenterology, Hepatology and Nutrition
Committee on Nutrition. J. Pediatr. Gastroenterol. Nutr. 2010, 50, 85–91. [CrossRef] [PubMed]
129. Griffin, I.J.; Domellöf, M.; Bhatia, J.; Anderson, D.M.; Kler, N. Zinc and copper requirements in preterm
infants: An examination of the current literature. Early Hum. Dev. 2013, 89, 29–34. [CrossRef] [PubMed]
130. Greene, H.L.; Hambidge, K.M.; Schanler, R.; Tsang, R.C. Guidelines for the use of vitamins, trace elements,
calcium, magnesium, and phosphorus in infants and children receiving total parenteral nutrition: Report of
the Subcommittee on Pediatric Parenteral Nutrient Requirements from the Committee on Clinical Practice
Issues of the American Society for Clinical Nutrition. Am. J. Clin. Nutr. 1988, 48, 1324–1342. [PubMed]
131. Schanler, R.J.; Shulman, R.J.; Prestridge, L.L. Parenteral Nutrient Needs of very Low Birth Weight Infants.
J. Pediatr. 1994, 125, 961–968. [CrossRef]
132. Higashi, A.; Ikeda, T.; Iribe, K.; Matsuda, I. Zinc Balance in Premature Infants Given the Minimal Dietary
Zinc Requirement. J. Pediatr. 1988, 112, 262–266. [CrossRef]
133. Altigani, M.; Murphy, J.F.; Gray, O.P. Plasma Zinc Concentration and Catch up Growth in Preterm Infants.
Acta Paediatr. Scand. Suppl. 1989, 357, 20–33. [CrossRef] [PubMed]
134. Marriott, L.D.; Foote, K.D.; Kimber, A.C.; Delves, H.T.; Morgan, J.B. Zinc, Copper, Selenium and Manganese
Blood Levels in Preterm Infants. Arch. Dis. Child. Fetal. Neonatal. 2007, 92, 494–497. [CrossRef] [PubMed]
135. Pang, Y.; Applegate, T.J. Effects of Dietary Copper Supplementation and Copper Source on Digesta pH,
Calcium, Zinc, and Copper Complex Size in the Gastrointestinal Tract of the Broiler Chicken. Poult. Sci.
2007, 86, 531–537. [CrossRef] [PubMed]
136. Smith, J.C., Jr. The Vitamin A—Zinc Connection: A review. Acad. Sci. 1980, 355, 62–74. [CrossRef]
137. Ahmed, F.; Barua, S.; Mohiduzzaman, M.; Shaheen, N.; Bhuyan, M.A.; Margetts, B.M.; Jackson, A.A.
Interactions between Growth and Nutrient Status in School-age children of Urban Bangladesh. Am. J.
Clin. Nutr. 1993, 58, 334–338. [PubMed]
© 2015 by the authors; licensee MDPI, Basel, Switzerland. This article is an open
access article distributed under the terms and conditions of the Creative Commons by
Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/).
10446
